Key points from article :
Mitrix Bio is testing tiny particles called “mitlets,” that contain mitochondria, to boost immune system strength.
Injections in animal models appear to reverse immune weakness.
Old or sick animals showed reduced cytokine storms and significantly improved survival against bacterial and viral infections.
After a few days, the new mitochondria seem to be discarded so the benefit wears off.
HISET (Human Immune System Energetic Transplantation Therapy) is expected to be compatible with other immunotherapies.
Mitrix expects to move HISET into human trials.
“If the results we are seeing translate to humans, the results would be roughly equivalent to making the human immune system 30 years younger,” said Tom Benson, CEO of Mitrix.
NOTE: Longevity.Technology has been contracted by Mitrix Bio to support its current funding round
